The Hidden Costs of Copay Cards: A Growing Headache for Patients
Jayant Mishra’s story, detailed in recent reports from KFF Health News and other outlets, is becoming increasingly common. Diagnosed with psoriatic arthritis in 2025, Mishra found initial relief with Otezla, a medication costing around $5,000 for a 30-day supply. A copay card from the manufacturer, Amgen, initially covered his costs. But that assistance vanished unexpectedly, leaving him facing substantial out-of-pocket expenses despite having insurance.
The Copay Card Promise and the Reality
Copay assistance programs are marketed as a lifeline for patients facing high drug costs. They aim to make essential medications accessible by reducing the financial burden at the pharmacy counter. However, the way these programs interact with insurance plans and pharmacy benefit managers (PBMs) is often complex and opaque, leading to unexpected bills. Mishra’s case highlights a critical issue: copay cards don’t always work as advertised.
His UnitedHealthcare plan, through OptumRx, didn’t apply any negotiated discount, covering only a fraction of the drug’s list price even with the copay card applied. This resulted in the card being depleted quickly and Mishra being responsible for a significant portion of the cost.
The “Tug-of-War” Between Drugmakers and Insurers
Experts like Aaron Kesselheim of Harvard Medical School describe the situation as a “tug-of-war” between pharmaceutical companies and insurers. Drugmakers offer copay cards to encourage the use of their brand-name drugs, while insurers and PBMs negotiate discounts and prefer certain medications on their formularies. This creates a system where patients can get caught in the middle.
A key problem is that many insurance plans don’t count copay assistance towards a patient’s deductible. This means patients must meet their deductible before their insurance kicks in, even if they’re using a copay card. Using a copay card can sometimes result in patients paying the full list price, rather than the discounted rate negotiated by their insurer.
The Role of Patent Protection and Generic Alternatives
The availability of generic alternatives can significantly impact drug costs. While a generic version of Otezla was approved in 2021, Amgen has actively pursued legal action to block its widespread availability in the U.S., maintaining patent protection until 2028. This limits competition and keeps the price of the brand-name drug artificially high. In contrast, generic Otezla is available in Canada and overseas for a fraction of the cost.
Did you grasp? Patients in other countries often have access to cheaper generic medications that are not readily available in the United States due to patent laws and legal challenges.
Future Trends and Potential Solutions
Several trends suggest this issue will likely worsen without intervention. Insurers are increasingly scrutinizing copay card usage, and manufacturers are seeking ways to circumvent these restrictions. This could lead to even more confusion and unexpected costs for patients.
Here are some potential future developments:
- Increased Transparency: Greater transparency in drug pricing and copay card terms is crucial. Patients need clear information about how these programs work and how they interact with their insurance.
- Regulatory Changes: Policymakers may consider regulations to address the complexities of copay assistance programs and ensure they truly benefit patients.
- Greater Use of Generic Drugs: Promoting the use of generic medications, where appropriate, can significantly lower costs.
- Plan Design Changes: Health plans could redesign their formularies and cost-sharing structures to better align incentives and reduce patient out-of-pocket expenses.
FAQ: Copay Cards and Your Medications
- What is a copay card? A copay card is a program offered by drug manufacturers to help patients with the out-of-pocket costs of their medications.
- Will a copay card always lower my costs? Not necessarily. It depends on your insurance plan and how the copay card interacts with your coverage.
- Do copay cards count towards my deductible? Often, no. Many insurance plans do not count copay assistance towards your deductible.
- What should I do if I receive an unexpected bill after using a copay card? Contact your insurance company and the drug manufacturer to understand the charges and explore potential solutions.
Pro Tip: Before starting a new medication with a copay card, call your insurance company to confirm how the card will work with your specific plan.
Mishra’s experience serves as a cautionary tale. While copay cards can be helpful, patients must understand the fine print and be prepared for potential surprises. Navigating the complex world of drug pricing requires vigilance and a proactive approach.
Want to learn more about managing your healthcare costs? Explore our articles on understanding health insurance and negotiating medical bills.
